Health ❯ Women's Health ❯ Menopause

Hormone Replacement Therapy

Risks and Benefits Dementia Risk Personalized Treatment Guidelines Cognitive Behavioral Therapy Treatment Options Advocacy Personal Experiences FDA Guidelines Risk Assessment of HRT Drug Interactions Breast Cancer Risk Cognitive Decline Menopause Symptoms Bone Health Vaginal Estrogen Tablets Legislation Alzheimer's Disease Cardiovascular Risks Oestrogen Cream Oestrogen Therapy Estrogen Products Clinical Guidelines FDA Regulations Clinical Practices Behavioral Support Workplace Rights

FDA Drops Broad Black-Box Warnings on Menopause Hormone Therapy

Labels will keep a boxed warning for endometrial cancer on estrogen‑alone products, with new guidance to start systemic therapy before age 60 or within 10 years of menopause.

FDA to Remove Most Boxed Warnings From Menopause Hormone Therapies

Study Links Early Menopause to Higher Dementia Risk as HRT Use Correlates With Lower Risk

Timing of Menopause Hormone Therapy Linked to Divergent Alzheimer’s Risks

Danish Study Finds No Link Between Vaginal Estrogen Tablets and Recurrent Ischemic Stroke

FDA Begins Expert Review of Menopause Hormone Therapy Warnings

Meta-Analysis Reveals Opposing Breast Cancer Risks of Hormone Replacement Therapy in Women Under 55